On the afternoon of June 20, 2023, under the guidance of Shenzhen Pingshan District Science and Technology Innovation Bureau, sponsored by Shenzhen Pingshan District biomedical Industry Innovation Chain Party Committee, Shenzhen Xingwan Biomedical Development Consulting Co., LTD., The 118th Shenzhen BioPark& Xingwan Hui Salon co-organized by Shenzhen Pingshan District High Level Talent Association - Shenzhen BioPark Entrepreneurs into Shenzhen Cell Valley activity was successfully held. Professor Wang Jianxun, chief scientist of Shenzhen Cell Valley, Luan Zhishi, Director of the General Office, Sun Rui, Deputy Director of Research and Development Department, and Yang Bolui, Director of Sales Department, warmly received the entrepreneurs and guests attending the salon.

 Luan Zhishi, director of the General Office, led the Shenzhen BioPark entrepreneurs to visit the 13th floor of the smart exhibition hall, the conference center and the administrative office area, and made a preliminary introduction to the founder team, corporate culture, development history and products and services.

 

At the symposium, chief scientist Professor Wang Jianxun introduced in detail the background of cell therapy, the current situation and development trend of the industry, the basic situation of Shenzhen Cell Valley, core products, application services, technical advantages and comprehensive strength. Afterwards, Professor Wang Jianxun had an in-depth exchange with the entrepreneurs and answered the technology-related questions raised by the entrepreneurs in detail. This symposium fully promoted the mutual exchange between enterprises, so that entrepreneurs can have a deeper understanding of the development trend of the cell and gene therapy industry and the application of key technologies, and also laid a solid foundation for subsequent cooperation. At the same time, it is also better to promote the sharing of resources between enterprises, accelerate the speed of technological development and product optimization, achieve mutual benefit and win-win situation, and promote the sustainable development of the field of cell and gene therapy.